Antiemetic efficacy of granisetron: A randomized crossover study in patients receiving cisplatin-containing intraarterial chemotherapy

Katsunori Uchida, Hideyuki Akaza, Kazunori Hattori, Ryosuke Noguchi, Fukuji Kondo, Satoru Ishikawa, Mikinobu Ohtani, Shiro Hinotsu, Kenkichi Koiso

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Cisplatin (CDDP) is one of the most active chemotherapeutic agents but is among the most emetogenic drugs. The emetic side-effects of CDDP-containing intraarterial chemotherapy have not been evaluated in a prospective randomized trial and the efficacy of serotonin antagonists in preventing the emesis associated with this method of CDDP administration has not been assessed. Methods: CDDP 50 mg/m2 and methotrexate 30 mg/m2 were administered every 3 weeks through intraarterial catheters placed in the bilateral internal iliac arteries. Patients were classified into two groups: granisetron treatment group (group G) and no treatment group (group NG) with the first course of chemotherapy, crossing over with the second course. The patients in group G received granisetron 40 μg/kg by intravenous infusion. Results: Although intraarterial CDDP administration produced less emesis than intravenous CDDP administration, at the same concentration, gastrointestinal toxicity is still the most unpleasant side-effect for patients. Granisetron administration significantly reduced nausea and vomiting during the acute emetic phase (an evaluation of treatment as very effective and effective was made in 89% in group G and 33% in group NG (P < 0.001). Complete control of emesis was achieved in 68 and 18% of patients in groups G and NG, respectively (P < 0.0001). Conclusion: A single prophylactic infusion of granisetron was effective in preventing the nausea and vomiting associated with intraarterial CDDP-containing therapy.

Original languageEnglish
Pages (from-to)87-91
Number of pages5
JournalJapanese journal of clinical oncology
Volume29
Issue number2
DOIs
Publication statusPublished - Feb 1999

Keywords

  • Anti-emetic efficacy
  • Bladder cancer
  • Cisplatin
  • Crossover trial
  • Granisetron
  • Intra-arterial chemotherapy

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Fingerprint Dive into the research topics of 'Antiemetic efficacy of granisetron: A randomized crossover study in patients receiving cisplatin-containing intraarterial chemotherapy'. Together they form a unique fingerprint.

  • Cite this